Chinese herbal medicine may improve outcomes after STEMI

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and

Traditional Chinese medicine Tongxinluo may improve heart health

The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects

Body mass index trajectories during mid to late life and risks of mortality and cardiovascular outcomes: Results from four prospective cohorts - eClinicalMedicine

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis - ScienceDirect

Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI

The role of cardiac rehabilitation in improving cardiovascular outcomes

GW26-e3856 Danhong Injection (A Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-analysis

A Chinese Drug Made of Insects May Help Cardiac Patients

Diabetes and Dietary Supplements: What You Need To Know

PDF) Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction